4-year overall survival for patients with advanced NSCLC treated with pembrolizumab: Results from KEYNOTE-001.

被引：2
|
作者：
Felip, Enriqueta
Hellmann, Matthew David
Hui, Rina
Carcereny, Enric
Leighl, Natasha B.
Ahn, Myung-Ju
Eder, Joseph Paul
Balmanoukian, Ani Sarkis
Aggarwal, Charu
Horn, Leora
Patnaik, Amita
Gubens, Matthew A.
Ramalingam, Suresh S.
Jensen, Erin
Kush, Debra A.
Garon, Edward B.
机构：
[1] Vall Hebron Univ Hosp, VHIO, Barcelona, Spain
[2] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[3] Westmead Hosp, Sydney, NSW, Australia
[4] Univ Sydney, Sydney, NSW, Australia
[5] Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol, Med Oncol Dept, Badalona, Spain
[6] Princess Margaret Canc Ctr, Toronto, ON, Canada
[7] Samsung Med Ctr, Seoul, South Korea
[8] Yale Univ, New Haven, CT USA
[9] Angeles Clin & Res Inst, Los Angeles, CA USA
[10] Abramson Canc Ctr, Philadelphia, PA USA
[11] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[12] South Texas Accelerated Res Therapeut, San Antonio, TX USA
[13] Univ Calif San Francisco, San Francisco, CA 94143 USA
[14] Emory Univ, Winship Canc Inst, Atlanta, GA USA
[15] Merck & Co Inc, Kenilworth, NJ USA
[16] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.9030
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9030
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Five-year long-term overall survival for patients with advanced NSCLC treated with pembrolizumab: Results from KEYNOTE-001.
    Garon, Edward B.
    Hellmann, Matthew David
    Costa, Enric Carcereny
    Leighl, Natasha B.
    Ahn, Myung-Ju
    Eder, Joseph Paul
    Balmanoukian, Ani Sarkis
    Aggarwal, Charu
    Horn, Leora
    Patnaik, Amita
    Gubens, Matthew A.
    Ramalingam, Suresh S.
    Felip, Enriqueta
    Scalzo, Cathie
    Jensen, Erin
    Kush, Debra A.
    Hui, Rina
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (18)
  • [2] Three-year overall survival for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001.
    Robert, Caroline
    Ribas, Antoni
    Hamid, Omid
    Daud, Adil
    Wolchok, Jedd D.
    Joshua, Anthony M.
    Hwu, Wen-Jen
    Weber, Jeffrey S.
    Gangadhar, Tara C.
    Joseph, Richard Wayne
    Dronca, Roxana Stefania
    Patnaik, Amita
    Zarour, Hassane M.
    Kefford, Richard
    Hersey, Peter
    Li, Xiaoyun
    Diede, Scott J.
    Ebbinghaus, Scot
    Hodi, F. Stephen
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [3] KEYNOTE-001: 3-year overall survival for patients with advanced NSCLC treated with pembrolizumab.
    Leigh, Natasha B.
    Hellmann, Matthew David
    Hui, Rina
    Costa, Enric Carcereny
    Felip, Enriqueta
    Ahn, Myung-Ju
    Eder, Joseph Paul
    Balmanoukian, Ani Sarkis
    Aggarwal, Charu
    Horn, Leora
    Patnaik, Amita
    Gubens, Matthew A.
    Ramalingam, Suresh S.
    Lubiniecki, Gregory M.
    Zhang, Jin
    Piperdi, Bilal
    Garon, Edward B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [4] THREE-YEAR OVERALL SURVIVAL FOR PATIENTS WITH ADVANCED MELANOMA TREATED WITH PEMBROLIZUMAB IN KEYNOTE-001
    Manders, P.
    Joshua, A. M.
    Kefford, R.
    Robert, C.
    Ribas, A.
    Hamid, O.
    Daud, A.
    Wolchok, J. D.
    Hwu, W-J
    Weber, J. S.
    Gangadhar, T. C.
    Joseph, R.
    Dronca, R.
    Patnaik, A.
    Zarour, H.
    Hersey, P.
    Li, X. N.
    Diede, S. J.
    Ebbinghaus, S.
    Hodi, F. S.
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 47 - 48
  • [5] 3-Year Overall Survival for Patients with Advanced NSCLC Treated with Pembrolizumab
    Hellmann, Matthew D.
    Leighl, Natasha B.
    Hui, Rina
    Carcereny, Enric
    Felip, Enriqueta
    Ahn, Myung-Ju
    Eder, Joseph Paul
    Balmanoukian, Ani S.
    Aggarwal, Charu
    Horn, Leora
    Patnaik, Amita
    Gubens, Matthew A.
    Ramalingam, Suresh S.
    Lubiniecki, Gregory M.
    Zhang, Jin
    Piperdi, Bilal
    Garon, Edward B.
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 60 - 61
  • [6] Risk of pneumonitis in patients with advanced NSCLC treated with pembrolizumab in KEYNOTE-001
    Ahn, M. -J.
    Gandhi, L.
    Hamid, O.
    Hellmann, M. D.
    Garon, E. B.
    Ramalingam, S. S.
    Lubiniecki, G. M.
    Zhang, J.
    Piperdi, B.
    Hui, R.
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : 140 - 140
  • [7] Patients (Pts) with advanced NSCLC from Korea treated with pembrolizumab (Pembro) in KEYNOTE-001
    Lee, J. -S.
    Lee, D. H.
    Piperdi, B.
    Zhang, J.
    Lubiniecki, G. M.
    Ahn, M. -J.
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : 141 - 141
  • [8] Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001
    Hamid, O.
    Robert, C.
    Daud, A.
    Hodi, F. S.
    Hwu, W. J.
    Kefford, R.
    Wolchok, J. D.
    Hersey, P.
    Joseph, R.
    Weber, J. S.
    Dronca, R.
    Mitchell, T. C.
    Patnaik, A.
    Zarour, H. M.
    Joshua, A. M.
    Zhao, Q.
    Jensen, E.
    Ahsan, S.
    Ibrahim, N.
    Ribas, A.
    [J]. ANNALS OF ONCOLOGY, 2019, 30 (04) : 582 - 588
  • [9] Five-Year Overall Survival for Patients With Advanced Non-Small-Cell Lung Cancer Treated With Pembrolizumab: Results From the Phase I KEYNOTE-001 Study
    Garon, Edward B.
    Hellmann, Matthew D.
    Rizvi, Naiyer A.
    Carcereny, Enric
    Leighl, Natasha B.
    Ahn, Myung-Ju
    Eder, Joseph Paul
    Balmanoukian, Ani S.
    Aggarwal, Charu
    Horn, Leora
    Patnaik, Amita
    Gubens, Matthew
    Ramalingam, Suresh S.
    Felip, Enriqueta
    Goldman, Jonathan W.
    Scalzo, Cathie
    Jensen, Erin
    Kush, Debra A.
    Hui, Rina
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (28) : 2518 - +
  • [10] 5-year survival outcomes in patients (pts) with advanced melanoma treated with pembrolizumab (pembro) in KEYNOTE-001
    Hamid, Omid
    Robert, Caroline
    Daud, Adil
    Hodi, F. Stephen
    Hwu, Wen-Jen
    Kefford, Richard
    Wolchok, Jedd D.
    Hersey, Peter
    Joseph, Richard Wayne
    Weber, Jeffrey S.
    Dronca, Roxana Stefania
    Mitchell, Tara C.
    Patnaik, Amita
    Zarour, Hassane M.
    Joshua, Anthony M.
    Jensen, Erin
    Ibrahim, Nageatte
    Ahsan, Sama
    Ribas, Antoni
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345